Rhupus syndrome in children : A multi-center retrospective cohort study and literature review
OBJECTIVE: In this study, we aimed to evaluate the characteristics of pediatric rhupus patients including all the related series in the literature.
METHODS: Thirty pediatric patients with rhupus syndrome from 12 different centers in Turkey were included in this study. The literature was also reviewed for pediatric patients with rhupus syndrome.
RESULTS: The most prominent phenotype of these 30 patients was juvenile idiopathic arthritis (JIA) (60%) at the disease onset and SLE (73.3%) at the last visit. Major SLE-related organ involvements were skin (80%), hematological system (53.3%), and kidney (23.3%). Arthritis was polyarticular (73.3%), asymmetric (66.7%), and erosive (53.3%) in most patients. Hydroxychloroquine (100%), glucocorticoids (86.7%), and mycophenolate mofetil (46.7%) were mostly used for SLE, while glucocorticoids (76.6%), methotrexate (73.3%), and nonsteroidal anti-inflammatory drugs (NSAIDs) (57.6%) were mainly preferred for JIA. Our literature search revealed 20 pediatric patients with rhupus syndrome (75% were RF positive). The most prominent phenotype was JIA (91.7%) at the disease onset and SLE (63.6%) at the last visit. Major SLE-related organ involvements were skin (66.7%), hematological system (58.3%), and kidney (58.3%). Arthritis was polyarticular (77.8%), asymmetric (63.6%), and erosive (83.3%) in most patients. Glucocorticoid (100%), hydroxychloroquine (76.9%), and azathioprine (46.2%) were mostly used for SLE, while methotrexate (76.9%) and NSAIDs (46.2%) were mainly preferred for the JIA phenotype.
CONCLUSION: Our study is the largest cohort in the literature evaluating pediatric rhupus cases. Most of the pediatric patients had polyarticular, asymmetric, and erosive arthritis, as well as organ involvements associated with SLE, including the skin, hematological system, and kidney.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Lupus - 33(2024), 3 vom: 12. Feb., Seite 273-281 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sener, Seher [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.02.2024 Date Revised 14.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/09612033231226353 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367170388 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367170388 | ||
| 003 | DE-627 | ||
| 005 | 20240214233117.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240116s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/09612033231226353 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1293.xml |
| 035 | |a (DE-627)NLM367170388 | ||
| 035 | |a (NLM)38226485 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sener, Seher |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rhupus syndrome in children |b A multi-center retrospective cohort study and literature review |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.02.2024 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a OBJECTIVE: In this study, we aimed to evaluate the characteristics of pediatric rhupus patients including all the related series in the literature | ||
| 520 | |a METHODS: Thirty pediatric patients with rhupus syndrome from 12 different centers in Turkey were included in this study. The literature was also reviewed for pediatric patients with rhupus syndrome | ||
| 520 | |a RESULTS: The most prominent phenotype of these 30 patients was juvenile idiopathic arthritis (JIA) (60%) at the disease onset and SLE (73.3%) at the last visit. Major SLE-related organ involvements were skin (80%), hematological system (53.3%), and kidney (23.3%). Arthritis was polyarticular (73.3%), asymmetric (66.7%), and erosive (53.3%) in most patients. Hydroxychloroquine (100%), glucocorticoids (86.7%), and mycophenolate mofetil (46.7%) were mostly used for SLE, while glucocorticoids (76.6%), methotrexate (73.3%), and nonsteroidal anti-inflammatory drugs (NSAIDs) (57.6%) were mainly preferred for JIA. Our literature search revealed 20 pediatric patients with rhupus syndrome (75% were RF positive). The most prominent phenotype was JIA (91.7%) at the disease onset and SLE (63.6%) at the last visit. Major SLE-related organ involvements were skin (66.7%), hematological system (58.3%), and kidney (58.3%). Arthritis was polyarticular (77.8%), asymmetric (63.6%), and erosive (83.3%) in most patients. Glucocorticoid (100%), hydroxychloroquine (76.9%), and azathioprine (46.2%) were mostly used for SLE, while methotrexate (76.9%) and NSAIDs (46.2%) were mainly preferred for the JIA phenotype | ||
| 520 | |a CONCLUSION: Our study is the largest cohort in the literature evaluating pediatric rhupus cases. Most of the pediatric patients had polyarticular, asymmetric, and erosive arthritis, as well as organ involvements associated with SLE, including the skin, hematological system, and kidney | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Juvenile idiopathic arthritis | |
| 650 | 4 | |a rhupus syndrome | |
| 650 | 4 | |a systemic lupus erythematosus | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 650 | 7 | |a Methotrexate |2 NLM | |
| 650 | 7 | |a YL5FZ2Y5U1 |2 NLM | |
| 650 | 7 | |a Glucocorticoids |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
| 700 | 1 | |a Batu, Ezgi Deniz |e verfasserin |4 aut | |
| 700 | 1 | |a Sahin, Sezgin |e verfasserin |4 aut | |
| 700 | 1 | |a Yildirim, Deniz Gezgin |e verfasserin |4 aut | |
| 700 | 1 | |a Ekinci, Miray Kisla |e verfasserin |4 aut | |
| 700 | 1 | |a Kisaoglu, Hakan |e verfasserin |4 aut | |
| 700 | 1 | |a Karali, Yasin |e verfasserin |4 aut | |
| 700 | 1 | |a Demir, Selcan |e verfasserin |4 aut | |
| 700 | 1 | |a Kaya Akca, Ummusen |e verfasserin |4 aut | |
| 700 | 1 | |a Gunalp, Aybuke |e verfasserin |4 aut | |
| 700 | 1 | |a Turkmen, Seyma |e verfasserin |4 aut | |
| 700 | 1 | |a Kavrul Kayaalp, Gulsah |e verfasserin |4 aut | |
| 700 | 1 | |a Arslanoglu, Ceyda |e verfasserin |4 aut | |
| 700 | 1 | |a Torun, Ruya |e verfasserin |4 aut | |
| 700 | 1 | |a Basaran, Ozge |e verfasserin |4 aut | |
| 700 | 1 | |a Pac Kisaarslan, Aysenur |e verfasserin |4 aut | |
| 700 | 1 | |a Sozeri, Betul |e verfasserin |4 aut | |
| 700 | 1 | |a Aktay Ayaz, Nuray |e verfasserin |4 aut | |
| 700 | 1 | |a Bakkaloglu, Sevcan Azime |e verfasserin |4 aut | |
| 700 | 1 | |a Kilic, Sara Sebnem |e verfasserin |4 aut | |
| 700 | 1 | |a Kalyoncu, Mukaddes |e verfasserin |4 aut | |
| 700 | 1 | |a Bilginer, Yelda |e verfasserin |4 aut | |
| 700 | 1 | |a Unsal, Erbil |e verfasserin |4 aut | |
| 700 | 1 | |a Kasapcopur, Ozgur |e verfasserin |4 aut | |
| 700 | 1 | |a Ozen, Seza |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lupus |d 1991 |g 33(2024), 3 vom: 12. Feb., Seite 273-281 |w (DE-627)NLM012651214 |x 1477-0962 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2024 |g number:3 |g day:12 |g month:02 |g pages:273-281 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/09612033231226353 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2024 |e 3 |b 12 |c 02 |h 273-281 | ||